Phase 3 Trial of Lu-177-Dotatate for Midgut Neuroendocrine Tumors

J Strosberg; G El-Haddad; E Wolin; A Hendifar; J Yao; B Chasen; E Mittra; PL Kunz; MH Kulke; H Jacene; D Bushnell; TM O'Dorisio; RP Baum; HR Kulkarni; M Caplin; R Lebtahi; T Hobday; E Delpassand; E van Cutsem; A Benson; R Srirajaskanthan; M Pavel; J Mora; J Berlin; E Grande; N Reed; E Seregni; K Oberg; ML Sierra; P Santoro; T Thevenet; JL Erion; P Ruszniewski; Dik Kwekkeboom; Eric Krenning

doi:10.1056/NEJMoa1607427

Phase 3 Trial of Lu-177-Dotatate for Midgut Neuroendocrine Tumors

J Strosberg
, G El-Haddad
, E Wolin
, A Hendifar
, J Yao
, B Chasen
, E Mittra
, PL Kunz
, MH Kulke
, H Jacene
, D Bushnell
, TM O'Dorisio
, RP Baum
, HR Kulkarni
, M Caplin
, R Lebtahi
, T Hobday
, E Delpassand
, E van Cutsem
, A Benson

R Srirajaskanthan, M Pavel, J Mora, J Berlin, E Grande, N Reed, E Seregni, K Oberg, ML Sierra, P Santoro, T Thevenet, JL Erion, P Ruszniewski, Dik Kwekkeboom, Eric Krenning

Radiology & Nuclear Medicine

Research output: Contribution to journal › Article › Academic › peer-review

2759 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	125-135
Number of pages	11
Journal	New England Journal of Medicine
Volume	376
Issue number	2
DOIs	https://doi.org/10.1056/NEJMoa1607427
Publication status	Published - 2017

Research programs

EMC MM-01-40-01

Access to Document

10.1056/NEJMoa1607427

http://hdl.handle.net/1765/95473

Cite this

Strosberg, J., El-Haddad, G., Wolin, E., Hendifar, A., Yao, J., Chasen, B., Mittra, E., Kunz, PL., Kulke, MH., Jacene, H., Bushnell, D., O'Dorisio, TM., Baum, RP., Kulkarni, HR., Caplin, M., Lebtahi, R., Hobday, T., Delpassand, E., van Cutsem, E., ... Krenning, E. (2017). Phase 3 Trial of Lu-177-Dotatate for Midgut Neuroendocrine Tumors. New England Journal of Medicine, 376(2), 125-135. https://doi.org/10.1056/NEJMoa1607427

@article{bffd120523e54c37b9ecb2f410868f0b,

title = "Phase 3 Trial of Lu-177-Dotatate for Midgut Neuroendocrine Tumors",

author = "J Strosberg and G El-Haddad and E Wolin and A Hendifar and J Yao and B Chasen and E Mittra and PL Kunz and MH Kulke and H Jacene and D Bushnell and TM O'Dorisio and RP Baum and HR Kulkarni and M Caplin and R Lebtahi and T Hobday and E Delpassand and \{van Cutsem\}, E and A Benson and R Srirajaskanthan and M Pavel and J Mora and J Berlin and E Grande and N Reed and E Seregni and K Oberg and ML Sierra and P Santoro and T Thevenet and JL Erion and P Ruszniewski and Dik Kwekkeboom and Eric Krenning",

year = "2017",

doi = "10.1056/NEJMoa1607427",

language = "Undefined/Unknown",

volume = "376",

pages = "125--135",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "2",

}

Strosberg, J, El-Haddad, G, Wolin, E, Hendifar, A, Yao, J, Chasen, B, Mittra, E, Kunz, PL, Kulke, MH, Jacene, H, Bushnell, D, O'Dorisio, TM, Baum, RP, Kulkarni, HR, Caplin, M, Lebtahi, R, Hobday, T, Delpassand, E, van Cutsem, E, Benson, A, Srirajaskanthan, R, Pavel, M, Mora, J, Berlin, J, Grande, E, Reed, N, Seregni, E, Oberg, K, Sierra, ML, Santoro, P, Thevenet, T, Erion, JL, Ruszniewski, P, Kwekkeboom, D & Krenning, E 2017, 'Phase 3 Trial of Lu-177-Dotatate for Midgut Neuroendocrine Tumors', New England Journal of Medicine, vol. 376, no. 2, pp. 125-135. https://doi.org/10.1056/NEJMoa1607427

TY - JOUR

T1 - Phase 3 Trial of Lu-177-Dotatate for Midgut Neuroendocrine Tumors

AU - Strosberg, J

AU - El-Haddad, G

AU - Wolin, E

AU - Hendifar, A

AU - Yao, J

AU - Chasen, B

AU - Mittra, E

AU - Kunz, PL

AU - Kulke, MH

AU - Jacene, H

AU - Bushnell, D

AU - O'Dorisio, TM

AU - Baum, RP

AU - Kulkarni, HR

AU - Caplin, M

AU - Lebtahi, R

AU - Hobday, T

AU - Delpassand, E

AU - van Cutsem, E

AU - Benson, A

AU - Srirajaskanthan, R

AU - Pavel, M

AU - Mora, J

AU - Berlin, J

AU - Grande, E

AU - Reed, N

AU - Seregni, E

AU - Oberg, K

AU - Sierra, ML

AU - Santoro, P

AU - Thevenet, T

AU - Erion, JL

AU - Ruszniewski, P

AU - Kwekkeboom, Dik

AU - Krenning, Eric

PY - 2017

Y1 - 2017

U2 - 10.1056/NEJMoa1607427

DO - 10.1056/NEJMoa1607427

M3 - Article

C2 - 28076709

SN - 0028-4793

VL - 376

SP - 125

EP - 135

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 2

ER -